Schedule 13D ownership disclosure
Monte Rosa Therapeutics Inc
Security class unavailable · CUSIP: 61225M102
Event date: 2024-08-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-198980
- Form type
- SC 13D
- Filer
- Monte Rosa Therapeutics, Inc.
- CIK
- CIK 1826457
- Filed
- Aug 12, 2024
- Reporting period
- Aug 08, 2024
- Description
- Schedule 13D beneficial ownership